» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: The effect of supplementation with vitamins A, D, E, C, B on disease severity and mortality in patients with COVID-19 Design: A randomized, double-blind, placebo-controlled clinical trial Settings and conduct: Only patients are unaware of the placement in the intervention or control group. Location: The intensive care unit is located at Imam Khomeini Hospital. Participants/Inclusion and exclusion criteria: Inclusion criteria : 1- Between 20 and 60 years old 2. Both men and women 3. The definitive or clinical diagnosis of COVID-19 4. Satisfaction with the study collaboration 5.BMI: 18.5-30 6. COVID-19 treatment protocol is almost identical in both groups 7- Patients not participating in other trials 8- No liver and kidney disorders Non-Entry Criteria: - Patients with rare and specific viral diseases such as HIV - Patients undergoing chemotherapy over the past month - Any other condition that the specialist diagnoses is very specific. Intervention groups: Patients were divided into intervention and control groups. Intervention group supplemented with vitamin D at 25,000 international units of vitamin A daily, 600,000 international units of vitamin D once daily, 300 units of vitamin E twice daily, 500 mg Vitamin C is taken 4 times a day and finally B vitamins are taken as a daily solute ampoule. The control group received no supplement or placebo. Main outcome variables: Variables: 1- Weight, height and BMI of patients 2. Severity of pulmonary involvement according to CT scan 3. Respiratory support (Insive or Non-Invasive) 4% oxygen saturation 5- Serum levels of WBC, CRP, IL6, TNF-α, IFN-G, ESR 6. The patient's body temperature 7. The presence or absence of involvement of other organs 8- Duration of hospitalization 9. Mortality
IRCTID: IRCT20200319046819N1
  1. The effect of combination of selenium, vitamin C and methylprednisolone in acute respiratory distress syndrome mortality and morbidity from COVID-19
  2. Comparing the effect of standard treatment with and without vitamin A supplementation in improving the clinical symptoms of outpatients with COVID-19
  3. The effect of vitamin A, B, C, D, and E supplementations on biochemical parameters of critically ill patients with COVID-19: A randomized clinical trial
  4. The effect of vitamin C and E in the treatment and clinical course of patients with SARS-cov2 (COVID-19)
  5. Effect of vitamin D supplementation in diagnosed cases of 2019 Novel Coronavirus; a randomized clinical trial
  6. The effect of simultaneous supplementation of oral vitamin D and intravenous vitamin C on inflammatory indices, oxidative stress and clinical outcomes in patients with acute respiratory failure admitted to the intensive care unit
  7. Effect of high dose vitamin D on serum Neuron Specific Enolase (NSE) level as a marker of neuronal damage in patients with ischemic stroke
  8. The frequency of mortality and morbidity following intertrochanteric fracture in patients over 60 years of age who received vitamin D compared to controls
  9. Investigating effect of Spirulina (Arthrospira platensis) dietary supplementation on COVID-19 disease outcomes in patients admitted to Intensive Care Units of hospitals: phase 2 clinical trial
  10. Effect of high dose Vitamin D3 on mortality, morbidity, length of stay in ICU and mechanical ventilation duration in pulmonary ICU patients.